COVID-19 WebinarsGlobal Health

COVID-19: The Invisible Impact on Team Members

By May 19, 2020April 22nd, 2021No Comments

JDD Multimedia

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

This webinar was previously recorded on May 13th, 2020 and is now available on demand.
Join colleagues and thought leaders as we examine the emotional and logistical impact of COVID-19 on employees. Panelists will discuss job loss, mental wellbeing, employee’s top concerns and communication surrounding the global coronavirus pandemic.
Experts will discuss ways to offset anxiety and depression, steps to take care of your emotional well-being and logistical challenges such as homeschooling and balancing the ever-changing priorities during this crisis. There will also be discussion surrounding manager communication strategies, what works, what does not work and ways employers can calm employee’s fears during the pandemic.

Moderator

  • Brandon Thompson
    (Co-Founder, Careers in Aesthetics & Co-Founder & CEO, BNB Aesthetic Innovations)

Faculty

  • Richard G. Fried, MD, PhD
    (Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates)
  •  John Connors
    (CEO & President, Jan Marini Skin Research)
  •  Mark Wilkins
    (Executive Vice President and U.S. General Manager, Prollenium Medical Technologies)
  •  Aaron Burton
    (CEO, Sciton)
  •  Jenna Mons Anderson
    (CEO, AccessElite)

You May Also Like

Journal of Drugs in Dermatology JDD Article About Looking for Curated Atopic Derm Content? We’ve Got You Covered.Atopic DermatitisFeatured ArticlesLatest NewsThe Latest
April 18, 2025

Looking for Curated Atopic Derm Content? We’ve Got You Covered!

Explore JDDonline If you’re on the hunt for expert-led, handpicked resources on atopic dermatitis, you’re in the right place. Whether you're brushing up on the latest treatment insights or looking…
Journal of Drugs in Dermatology JDD Article About Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the LiteratureFeatured ArticlesLatest NewsThe Latest
April 17, 2025

Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature

Could Rituximab Be the Key to Managing Epidermolysis Bullosa Acquisita? Epidermolysis bullosa acquisita (EBA) is a rare and often debilitating autoimmune blistering disease that remains notoriously difficult to manage. While…
Journal of Drugs in Dermatology JDD Article About An Innovative Cream Improves Signs and Symptoms of Dermatoporosis in Patients Aged 65 and OverFeatured ArticlesLatest NewsThe Latest
April 16, 2025

An Innovative Cream Improves Signs and Symptoms of Dermatoporosis in Patients Aged 65 and Over

A Breakthrough Approach to Aging Skin: Can This Cream Combat Dermatoporosis? As skin ages, it becomes fragile, thin, and prone to bruising - a condition known as dermatoporosis, which is…

Leave a Reply